MTOR and gastric cancer: In sinularin-treated gastric cancer (AGS and NCI-N87) cells, the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling was inactivated and lead to apoptosis [20].